medigraphic.com
Organo Oficial de la Sociedad Mexicana de Urología

2017, Number 1

<< Back Next >>

Rev Mex Urol 2017; 77 (1)

Association of glycemic control and erectil dysfunction in diabetic patients

Figueroa-García J, Pérez-Patraca AJ

Language: Spanish
References: 23
Page: 5-11
PDF size: 236.95 Kb.


ABSTRACT

Background: Erectile dysfunction is the inability to achieve and maintain an erection that enables satisfactory sexual penetration 50% of the time, within a 3-month period. Diabetes mellitus is the organic cause in 30% of cases, but despite this relation, the prevalence of erectile dysfunction is not well known in Mexico.
Objective: To determine the association between glycemic control and erectile dysfunction in diabetic patients.
Materials and Methods: An observational, cross-sectional, analytic study included diabetic patients that did not complain of complications at the time of the study. The International Index of Erectile Function (IIEF-5) questionnaire was applied to detect whether or not the patients presented with erectile dysfunction. Their glycated hemoglobin (HbA1c) levels were compared and the association with erectile dysfunction was analyzed through the odds ratio.
Results: The prevalence of erectile dysfunction in 362 patients was 72.3% (n=272). Of those patients with erectile dysfunction, 80.9% (n=212) had inadequate glycemic control, with an odds ratio of 6.92 (95% CI: 4.16 to 11.50).
Conclusions: The odds ratio of presenting with erectile dysfunction for diabetic men with inadequate glycemic control and patients with adequate glycemic control was 7:1.


REFERENCES

  1. Álvarez AE, Disfunción eréctil, Revista Médica Clínica Las Condes, 2009; 20(2): 227 -232

  2. Fong MER, Azuara JA, Prevalencia de disfunción eréctil en pacientes diabéticos, Medicina Interna Mexico, 2007; 23(6):477-80

  3. Rodríguez VL, Disfunción eréctil, Actas Urológicas Españolas, 2002; 26 (9): 667-690.

  4. Carlos-Sanchez RJ, González-López E, Disfunción erectile, sep 2009. 1745: 26-33

  5. Derosa G, Glyco-metabolic profile among type 2 diabetic patients with erectile dysfunction, Endocrine Journal. 2012; 59 (7): 611-619.

  6. Garg S, Study of erectile dysfunction in type-2 diabetic patients, International Journal of Healthcare & Biomedical Research, April 2013; 1 (3): 210-216.

  7. Romero-Mestre JC,Licea-Puig ME, Disfunción sexual eréctil en la diabetes mellitus, Revista Cubana Endocrinolgía. 2000; 11(2):105-20.

  8. Sánchez-Ruiz JC, González-López E, Disfunción eréctil, JANO 2009. N.º 1.745: 27- 33

  9. Barroso-Aguirre J, Ugarte-Romano F, Pimentel-Nieto A, Prevalencia de disfunción eréctil en hombres de 18 a 40 años en México y factores de riesgo asociados, Perinatología y reproducción humana. 2001; 15 (4): 254-261.

  10. López-Cruz M, Disfunción eréctil en portadores de diabetes mellitus tipo 2 en edad productive, Revista Medica de Chile. 2013; 141: 1555-1559.

  11. Juárez-Bengoa A, Aspectos clínicos de la disfunción eréctil en el paciente con diabetes mellitus tipo 2, Perinatología y Reproducción Humana. 2009; 23 (3): 169-177.

  12. Flores-López ME, Control metabólico, estado nutricional y presión arterial en diabéticos tipo 2. Eficacia de una estrategia educativa. Rev Med Ins Mex Seguro Soc. 2008; 46 (3): 301-310.

  13. Encuesta Nacional de Salud y Nutrición. México, 2012. Recuperada febrero 2015, en: http://ensanut.insp.mx/.

  14. Vargas-Mendoza JE, Chaparro-Galaor Y, Disfunción eréctil en pacientes con diabetes mellitus, Centro Regional de Investigación en Psicología; 6 (1): 37-41.

  15. López M Cruz M, Heredia V M. Elvira, González H Ricardo, Rosales P Eusebio. Disfunción eréctil en portadores de diabetes mellitus tipo 2 en edad productiva. Rev. méd. Chile, 2013, en: http://www.scielo.cl/scielo.php?script=sci_ arttext&pid=S0034-98872013001200009&lng=es.

  16. Molecular mechanisms associated with diabetic endothelial-erectile dysfunction. Nat Rev Urol 2016; 13:266-274.

  17. Guay AT. ED 2: erectile dysfunction and endothelial dysfunction. Endocrinol Metab Clin North Am 2007;36:453

  18. Yamasaki H, Ogawa K, Sasaki H, et al. Prevalence and risk factors of erectile dysfunction in Japanese men with type 2 diabetes. Diabetes Res Clin Pract 2004;66:S173-S177.

  19. Hannula V, Hautala NM, Tossavainen P, et al. Social wellbeing of young adults with type 1 diabetes since childhood. The Oulu cohort study of diabetic retinopathy. Scand J Public Health 2015;43:623-628.

  20. E. Malavige LS, Levy JC. Erectile dysfunction in diabetes mellitus. J Sex Med 2009; 6:1232-1247.

  21. Furakawa S., Sakai T., Niyya T, et al. Nocturia and prevalence of erectile dysfunction in Japanese patients with type 2 diabetes mellitus: The Dogo Study. J Diabetes Investig 2016; 7: 786–790

  22. Thorve VS, Kshirsagar AD, Vyawahare NS, et al. Diabetesinduced erectile dysfunction: epidemiology, pathophysiology and management. J jdiacomp March–April 2011: (25)2, 129–13.

  23. Santi D, Granata AR, Guidi A, et al. Six months of daily treatment with vardenafil improves parameters of endothelial inflammation and of hypogonadism in male patients with type 2 diabetes and erectile dysfunction: a randomized, double-blind, prospective trial. Eur J Endocrinol 2016; 174:513-522.




2020     |     www.medigraphic.com